Skip to main content
BFB
NYSE Manufacturing

Brown-Forman Reports 17% EPS Decline, $132M Brand Impairments, and Weak 2027 Outlook

Analysis by Wiseek AI
Sentiment info
Negative
Importance info
8
Price
$27.01
Mkt Cap
$12.488B
52W Low
$22.61
52W High
$31.92
Market data snapshot near publication time

Summary

Brown-Forman reported a 17% drop in full-year EPS, $132 million in brand impairments, and issued weak guidance for fiscal 2027, projecting flat organic net sales and declining operating income, despite completing a $400 million share repurchase.


Key Events

  • Full-Year Financial Decline

    Diluted EPS decreased 17% to $1.53, operating income fell 10% to $1.0 billion, and net sales declined 1% to $3.9 billion for fiscal year 2026.

  • Significant Brand Impairments

    The company recorded $132 million in non-cash impairment charges for the Gin Mare ($45M) and Diplomático ($87M) brand names, citing a softening category and challenging macroeconomic conditions.

  • Weak Fiscal 2027 Guidance

    Management expects organic net sales to be approximately flat and organic operating income to decline in the 3% to 5% range for fiscal year 2027.

  • Share Repurchase and Dividend Increase

    Brown-Forman completed a $400 million share repurchase program in December 2025 and increased its quarterly cash dividend by 2% in November 2025.


Analysis

Brown-Forman's annual report reveals a challenging fiscal year 2026, with diluted earnings per share falling 17% to $1.53 and operating income decreasing 10% to $1.0 billion. The company recognized significant non-cash impairment charges totaling $132 million for its Gin Mare and Diplomático brand names, reflecting a softening category outlook and a difficult macroeconomic environment. Looking ahead, fiscal 2027 guidance projects approximately flat organic net sales and a 3% to 5% decline in organic operating income, indicating continued headwinds. While the company completed a $400 million share repurchase program and increased its quarterly dividend by 2%, these positive capital allocation actions are overshadowed by the declining performance and cautious outlook. Additionally, one-time cash recognition awards totaling approximately $4.9 million were approved for executives involved in previously terminated business combination discussions, which may raise governance questions given the company's performance.

At the time of this filing, BFB was trading at $27.01 on NYSE in the Manufacturing sector, with a market capitalization of approximately $12.5B. The 52-week trading range was $22.61 to $31.92. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BFB - Latest Insights